Paper37972731
Apolipoprotein C3: form begets function.
Bornfeldt KE. J Lipid Res, 2024. Cited by 39 papers, by iCite.
11 sourcespapers-2026-11-12-0.1.0
Cite this record
ConductScience Library. Apolipoprotein C3: form begets function. Papers, record 37972731. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/37972731
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics7
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Lipoproteins | Major topic |
| Atherosclerosis | Major topic |
| Mice | |
| Animals | |
| Humans | |
| Apolipoprotein C-III | |
| Triglycerides |
Source PubMed
Grants5
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by | Source |
|---|---|---|---|---|---|
| R35 HL150754 | NHLBI NIH HHS | United States | R35HL150754 | PubMed and NIH | NIH RePORTER |
| R01 HL149685 | NHLBI NIH HHS | United States | R01HL149685 | PubMed and NIH | NIH RePORTER |
| R01 HL161829 | NHLBI NIH HHS | United States | R01HL161829 | PubMed and NIH | NIH RePORTER |
| P01 HL151328 | NHLBI NIH HHS | United States | P01HL151328 | PubMed and NIH | NIH RePORTER |
| P30 DK017047 | NIDDK NIH HHS | United States | P30DK017047 | PubMed and NIH | NIH RePORTER |
References86
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 9885288 | Intracellular processing of endocytosed triglyceride-rich lipoproteins comprises both recycling and degradation. | J Cell Sci | 1999 | https://conductscience.org/library/papers/9885288 | PubMed |
| 2 | 30320124 | Endothelial Transcytosis of Lipoproteins in Atherosclerosis. | Front Cardiovasc Med | 2018 | https://conductscience.org/library/papers/30320124 | PubMed |
| 3 | 37439258 | Independent Causal Effect of Remnant Cholesterol on Atherosclerotic Cardiovascular Outcomes: A Mendelian Randomization Study. | Arterioscler Thromb Vasc Biol | 2023 | https://conductscience.org/library/papers/37439258 | PubMed |
| 4 | 34937388 | Pharmacological Inhibition of CETP (Cholesteryl Ester Transfer Protein) Increases HDL (High-Density Lipoprotein) That Contains ApoC3 and Other HDL Subspecies Associated With Higher Risk of Coronary Heart Disease. | Arterioscler Thromb Vasc Biol | 2022 | https://conductscience.org/library/papers/34937388 | PubMed |
| 5 | 36781986 | Reply to: Apolipoprotein C3 induces inflammasome activation only in its delipidated form. | Nat Immunol | 2023 | https://conductscience.org/library/papers/36781986 | PubMed |
| 6 | 35187136 | Targeting ApoC3 Paradoxically Aggravates Atherosclerosis in Hamsters With Severe Refractory Hypercholesterolemia. | Front Cardiovasc Med | 2022 | https://conductscience.org/library/papers/35187136 | PubMed |
| 7 | 30723097 | Fructose-induced hypertriglyceridemia in rhesus macaques is attenuated with fish oil or ApoC3 RNA interference. | J Lipid Res | 2019 | https://conductscience.org/library/papers/30723097 | PubMed |
| 8 | 26633899 | The Association of Human Apolipoprotein C-III Sialylation Proteoforms with Plasma Triglycerides. | PLoS One | 2015 | https://conductscience.org/library/papers/26633899 | PubMed |
| 9 | 30972934 | Role of apolipoprotein C-III overproduction in diabetic dyslipidaemia. | Diabetes Obes Metab | 2019 | https://conductscience.org/library/papers/30972934 | PubMed |
| 10 | 19622837 | Expression of apolipoprotein C-III in McA-RH7777 cells enhances VLDL assembly and secretion under lipid-rich conditions. | J Lipid Res | 2010 | https://conductscience.org/library/papers/19622837 | PubMed |
| 11 | 10907114 | Triglycerides, apo C3 and Lp B:C3 and cardiovascular risk in type II diabetes. | Diabetologia | 2000 | https://conductscience.org/library/papers/10907114 | PubMed |
| 12 | 12401896 | ApoC-III content of apoB-containing lipoproteins is associated with binding to the vascular proteoglycan biglycan. | J Lipid Res | 2002 | https://conductscience.org/library/papers/12401896 | PubMed |
| 13 | 35025993 | Apolipoprotein C-III reduction in subjects with moderate hypertriglyceridaemia and at high cardiovascular risk. | Eur Heart J | 2022 | https://conductscience.org/library/papers/35025993 | PubMed |
| 14 | 3973011 | Modulation of lipoprotein lipase activity by apolipoproteins. Effect of apolipoprotein C-III. | J Clin Invest | 1985 | https://conductscience.org/library/papers/3973011 | PubMed |
| 15 | 31092690 | ApoC-III ASO promotes tissue LPL activity in the absence of apoE-mediated TRL clearance. | J Lipid Res | 2019 | https://conductscience.org/library/papers/31092690 | PubMed |
| 16 | 35653195 | Interventional hepatic apoC-III knockdown improves atherosclerotic plaque stability and remodeling by triglyceride lowering. | JCI Insight | 2022 | https://conductscience.org/library/papers/35653195 | PubMed |
| 17 | 30580564 | Effects of APOC3 Heterozygous Deficiency on Plasma Lipid and Lipoprotein Metabolism. | Arterioscler Thromb Vasc Biol | 2019 | https://conductscience.org/library/papers/30580564 | PubMed |
| 18 | 17200715 | Liver heparan sulfate proteoglycans mediate clearance of triglyceride-rich lipoproteins independently of LDL receptor family members. | J Clin Invest | 2007 | https://conductscience.org/library/papers/17200715 | PubMed |
| 19 | 31329855 | N-acetyl galactosamine-conjugated antisense drug to APOC3 mRNA, triglycerides and atherogenic lipoprotein levels. | Eur Heart J | 2019 | https://conductscience.org/library/papers/31329855 | PubMed |
| 20 | 31390883 | ApoC-III Glycoforms Are Differentially Cleared by Hepatic TRL (Triglyceride-Rich Lipoprotein) Receptors. | Arterioscler Thromb Vasc Biol | 2019 | https://conductscience.org/library/papers/31390883 | PubMed |
Cited by31
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 39 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42897897 | Cognitive Functions and Gene Polymorphism Associated with Cardiovascular Risk in Young Adults vs. Patients with Arterial Hypertension. | Curr Hypertens Rev | 2026 | https://conductscience.org/library/papers/42897897 | PubMed |
| 42820004 | Hypertriglyceridemia: Causes, Consequences, Diagnosis, and Management. | MedComm (2020) | 2026 | https://conductscience.org/library/papers/42820004 | PubMed |
| 42658581 | Macrophage TREM2 is a triglyceride-rich lipoprotein receptor that undergoes shedding in prediabetic hepatic steatosis. | JCI Insight | 2026 | https://conductscience.org/library/papers/42658581 | PubMed |
| 42241512 | Hepatic Lipoprotein Production, Cardiometabolic Phenotypes, and Subtypes of Steatotic Liver Disease. | Circ Res | 2026 | https://conductscience.org/library/papers/42241512 | PubMed |
| 42137733 | Association of apolipoprotein C-III with atherosclerotic cardiovascular disease and the effectiveness of simulated interventions. | J Geriatr Cardiol | 2026 | https://conductscience.org/library/papers/42137733 | PubMed |
| 42091260 | Atherogenic apolipoprotein C-III may not be as bad as we thought. | J Thromb Haemost | 2026 | https://conductscience.org/library/papers/42091260 | PubMed |
| 42074213 | Current and Emerging Pharmacological Therapies for Hypertriglyceridemia. | Int J Mol Sci | 2026 | https://conductscience.org/library/papers/42074213 | PubMed |
| 42010388 | Olezarsen in Hypertriglyceridemia With High Cardiac Risk: A GRADE-Assessed Meta-Analysis of Randomized Trials With Trial Sequential Evidence. | Endocrinol Diabetes Metab | 2026 | https://conductscience.org/library/papers/42010388 | PubMed |
| 41734579 | Apolipoprotein C3 exacerbates vascular calcification by promoting ferroptosis via the TLR2/AMPK pathway in vascular smooth muscle cells. | Redox Biol | 2026 | https://conductscience.org/library/papers/41734579 | PubMed |
| 41669684 | Efficacy and safety of small interfering RNA (siRNA) therapies for hypertriglyceridemia and mixed dyslipidemia: an updated systematic review and meta-analysis. | Front Pharmacol | 2026 | https://conductscience.org/library/papers/41669684 | PubMed |
| 41617039 | Elevated levels of apolipoprotein C3 impair platelet function and reduce thrombosis. | J Thromb Haemost | 2026 | https://conductscience.org/library/papers/41617039 | PubMed |
| 41516253 | Rodent Models for Atherosclerosis. | Int J Mol Sci | 2025 | https://conductscience.org/library/papers/41516253 | PubMed |
| 41374009 | Dysapolipoproteinaemia Influences the Relationship Between Very Low-Density Lipoprotein Cholesterol and Intra-Pancreatic Fat Deposition in Humans. | Nutrients | 2025 | https://conductscience.org/library/papers/41374009 | PubMed |
| 41226726 | Changes in Apolipoprotein A1-Associated Proteomic Composition After Pioglitazone Treatment Versus Weight Loss. | Int J Mol Sci | 2025 | https://conductscience.org/library/papers/41226726 | PubMed |
| 41188883 | Remnant cholesterol, low-density lipoprotein cholesterol and atherosclerotic cardiovascular disease in metabolic dysfunction-associated steatotic liver disease: a cohort study. | Lipids Health Dis | 2025 | https://conductscience.org/library/papers/41188883 | PubMed |
| 41062288 | Evinacumab Improved the Homozygous Familial Hypercholesterolemia Lipid Metabolism: A Case Report. | J Atheroscler Thromb | 2026 | https://conductscience.org/library/papers/41062288 | PubMed |
| 41002378 | ApoC3 Attenuates Platelet Activation Through GPIIb/IIIa Receptor Interaction. | Cells | 2025 | https://conductscience.org/library/papers/41002378 | PubMed |
| 40933828 | HDL from 36-h fasted participants potently promotes efflux of cholesteryl ester from activated microglia. | Front Aging Neurosci | 2025 | https://conductscience.org/library/papers/40933828 | PubMed |
| 40728654 | JAM-A: Adhesion Receptor and Signaling Regulator in Atherosclerosis. | Curr Atheroscler Rep | 2025 | https://conductscience.org/library/papers/40728654 | PubMed |
| 40679547 | ApoC-III as Therapeutic Target: Is it Primetime for Clinical Use? | Curr Atheroscler Rep | 2025 | https://conductscience.org/library/papers/40679547 | PubMed |
Genes19
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Trials
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/37972731
GET https://conductscience.org/api/papers/v1/37972731/references?page=2